Serdar E. Bulun

ORCID: 0000-0003-0850-8637 · 134 papers in corpus
lab-animal 2012
Fertility and sterility ·doi:10.1016/j.fertnstert.2012.03.030

OBJECTIVE: To define altered gene expression networks in endometriosis. DESIGN: Experiments using endometriotic tissues and primary cells. SETTING: Division of Reproductive Biology Research, Northwestern University. PATIENT(S): Premenopa…

review 2012
Fertility and sterility ·doi:10.1016/j.fertnstert.2012.08.053

OBJECTIVE: To review the use of aromatase inhibitors (AIs) for the treatment of endometriosis. DESIGN: Literature review. CONCLUSION(S): Most studies show that in reproductive-age women, the combination of AI with conventional therapy all…

lab-animal 2012
Fertility and sterility ·doi:10.1016/j.fertnstert.2012.11.021

OBJECTIVE: To determine the effect of inhibiting aromatase activity on endometrial lesion growth and aromatase expression in a baboon model of induced endometriosis. DESIGN: Prospective study. SETTING: Primate research institute. ANIMAL(…

review 2012
Nature medicine ·doi:10.1038/nm.2855

Endometriosis is an estrogen-dependent disease. The biologically active estrogen, estradiol, aggravates the pathological processes (e.g., inflammation and growth) and the symptoms (e.g., pain) associated with endometriosis. Abundant quantit…

2012
·doi:10.1016/j.fertnstert.2012.07.334
lab-animal 2012
·doi:10.1093/biolreprod/87.s1.321

Endometriosis is an estrogen-dependent gynecological disease that affects 6–10% of women of reproductive age. It is a major cause of chronic pelvic pain and infertility, and poses a heavy financial burden on society, with annual estimates t…

2012
·doi:10.1016/j.fertnstert.2012.07.241
lab-animal 2012
PloS one ·doi:10.1371/journal.pone.0029021

BACKGROUND: Progesterone, via its nuclear receptor (PR), exerts an overall tumorigenic effect on both uterine fibroid (leiomyoma) and breast cancer tissues, whereas the antiprogestin RU486 inhibits growth of these tissues through an unknown…

2012
·doi:10.1093/biolreprod/87.s1.280

Endometriosis is a benign gynecological disease causing infertility, adhesions and chronic pain in approximately 10% of reproductively-aged women due to the extrauterine growth of endometrial stromal and glandular cells. Endometriotic lesio…

2012
review 2012
Seminars in reproductive medicine ·doi:10.1055/s-0031-1299596

Endometriosis is an estrogen-dependent disease. The biologically active estrogen, estradiol, aggravates the pathological processes (e.g., inflammation and growth) and the symptoms (e.g., pain) associated with endometriosis. Abundant quantit…

2011
·doi:10.1016/j.fertnstert.2011.07.531
2011
·doi:10.1016/j.fertnstert.2011.07.379
other 2011
Fertility and sterility ·doi:10.1016/j.fertnstert.2011.07.1136

OBJECTIVE: To evaluate the use of an aromatase inhibitor for the treatment of endometriosis-related chronic pelvic pain. DESIGN: Retrospective analysis. SETTING: Academic medical center outpatient reproductive endocrinology clinic. PATIE…

other 2011
Lung cancer (Amsterdam, Netherlands) ·doi:10.1016/j.lungcan.2011.01.003

In humans, aromatase (CYP19) gene expression is regulated via alternative promoters. Activation of each promoter gives rise to a CYP19 mRNA species with a unique 5'-untranslated region. Inhibition of aromatase has been reported to downregul…

other 2011
Human Reproduction ·doi:10.1093/humrep/der172

BACKGROUND: Retinoic acid (RA) regulates key biological processes, including differentiation, apoptosis and cell survival. RA mediates induction of 17 beta-hydroxysteroid dehydrogenase type 2 mRNA, catalyzing the conversion of estradiol to …

other 2011
Reproductive sciences (Thousand Oaks, Calif.) ·doi:10.1177/1933719111404614

UNLABELLED: Endometriosis is an estrogen-dependent disease. Steroidogenic factor 1 (SF-1), a transcription factor, is essential for the activation of multiple steroidogenic genes for estrogen biosynthesis in endometriosis-derived stromal ce…

review 2011
·doi:10.1002/9781444398519.ch35

Approximately half of women with endometriosis achieve pain relief from existing medical or surgical treatments. Medical treatments are usually directed at inhibiting estrogen action or its production from the ovaries and do not address loc…

2011
·doi:10.1210/endo-meetings.2011.part3.p25.p3-180
review 2010
Seminars in reproductive medicine ·doi:10.1055/s-0029-1242992

Estradiol (E2) stimulates the growth and inflammation in the ectopic endometriotic tissue that commonly resides on the pelvic organs. Several clinical and laboratory-based observations are indicative of resistance to progesterone action in …

lab-animal 2010
The Journal of clinical endocrinology and metabolism ·doi:10.1210/jc.2010-0459

CONTEXT: Retinoic acid (RA) controls multiple biological processes via exerting opposing effects on cell survival. Retinol uptake into cells is controlled by stimulated by RA 6 (STRA6). RA is then produced from retinol in the cytosol. Parti…

review 2010
Seminars in reproductive medicine ·doi:10.1055/s-0029-1242991

Loss of progesterone signaling in the endometrium may be a causal factor in the development of endometriosis, and progesterone resistance is commonly observed in women with this disease. In endometriotic stromal cells, the levels of progest…

2010
·doi:10.4324/9780203319390_chapter_9
lab-animal 2010
Fertility and sterility ·doi:10.1016/j.fertnstert.2009.11.031

OBJECTIVE: To evaluate the effects of selective P receptor (PR) modulator CDB4124 on cell proliferation and apoptosis in cultured human uterine leiomyoma smooth muscle (LSM) cells and control myometrial smooth muscle (MSM) cells in matched …

review 2009
Human Reproduction ·doi:10.1093/humrep/dep045

In response to the pressing need for more efficacious and safer therapeutics for endometriosis, there have been numerous reports in the last decade of positive results from animal and in vitro studies of various compounds as potential thera…